Cited by 63Bipolar Disorder and TreatmentMeta-analysis and systematic reviewsSchizophrenia research and treatment

Bias in emerging biomarkers for bipolar disorder

Open access
Carvalho, A. F., Köhler, C. A., Fernandes, B. S., Quevedo, J., Miskowiak, K. W., Brunoni, A. R., Machado-Vieira, R., Maes, M. +2 more·2016·Psychological Medicine

Abstract

Background: To date no comprehensive evaluation has appraised the likelihood of bias or the strength of the evidence of peripheral biomarkers for bipolar disorder (BD). Here we performed an umbrella review of meta-analyses of peripheral non-genetic biomarkers for BD. Method: The Pubmed/Medline, EMBASE and PsycInfo electronic databases were searched up to May 2015. Two independent authors conducted searches, examined references for eligibility, and extracted data. Meta-analyses in any language examining peripheral non-genetic biomarkers in participants with BD (across different mood states) compared to unaffected controls were included. Results: Six references, which examined 13 biomarkers across 20 meta-analyses (5474 BD cases and 4823 healthy controls) met inclusion criteria. Evidence for excess of significance bias (i.e. bias favoring publication of ‘positive’ nominally significant results) was observed in 11 meta-analyses. Heterogeneity was high for (I2 ⩾ 50%) 16 meta-analyses. Only two biomarkers met criteria for suggestive evidence namely the soluble IL-2 receptor and morning cortisol. The median power of included studies, using the effect size of the largest dataset as the plausible true effect size of each meta-analysis, was 15.3%. Conclusions: Our findings suggest that there is an excess of statistically significant results in the literature of peripheral biomarkers for BD. Selective publication of ‘positive’ results and selective reporting of outcomes are possible mechanisms.

Integrity signals

Registry

Crossref · 10.1017/s0033291716000957

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The weaknesses of the ICD-11 and DSM-5 systems are debatable and unavoidable given the lack of any objective pathophysiological compass and the limited specificity of most currently available biomarkers in mental illness.

    “The weaknesses of the two systems are both debatable and unavoidable [43, 44] given the lack of any objective pathophysiological compass and the limited specificity of most currently available biomarkers in mental illness [45].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Carvalho, A. F., Köhler, C. A., Fernandes, B. S., Quevedo, J., Miskowiak, K. W., Brunoni, A. R., Machado-Vieira, R., Maes, M., Vieta, E., & Berk, M.
Affiliations
  • Universidade Federal do Ceará (BR)
  • Universidade Federal do Rio Grande do Sul (BR)
  • Universidade do Extremo Sul Catarinense (BR)
  • Copenhagen University Hospital (DK)
  • Universidade de São Paulo (BR)
  • Barwon Health (AU)
  • Centro de Investigación Biomédica en Red de Salud Mental (ES)
Corresponding author
Carvalho, A. F.
Venue
Psychological Medicine
Published
2016-05-19
Volume
46
Issue
11
Pages
2287-2297
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W2400490165
Cited by
63
References
55
Citations by year
2026: 1 · 2025: 4 · 2024: 5 · 2023: 5 · 2022: 3 · 2021: 2 · 2020: 8 · 2019: 6 · 2018: 11 · 2017: 15 · 2016: 3
FWCI
1.67
Type
journal article
Language
en
Open access
Locations
  • Psychological Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Figshare (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
bipolar disorder, peripheral biomarkers, publication bias, selective reporting, umbrella review of meta-analyses, soluble interleukin-2 receptor, morning cortisol, statistical power
MeSH terms
Bipolar Disorder, Humans, Biomarkers, Publication Bias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review